L. Vujanovic and L. H. Butterfield, Melanoma cancer vaccines and antitumor T cell responses, J. Cell Biochem, vol.102, pp.301-310, 2007.

E. Jager, H. Hohn, A. Necker, R. Forster, J. Karbach et al., Peptide-specific CD81T-cell evolution in vivo: response to peptide vaccination with Melan-A/MART-1, Int. J. Cancer, vol.98, pp.376-388, 2002.

E. Jager, M. Maeurer, H. Hohn, J. Karbach, D. Jager et al., Clonal expansion of Melan A-specific cytotoxic T lymphocytes in a melanoma patient responding to continued immunization with melanoma-associated peptides, Int. J. Cancer, vol.86, pp.538-547, 2000.

H. Benlalam, V. Vignard, A. Khammari, A. Bonnin, Y. Godet et al., Infusion of Melan-A/Mart-1 melanoma patients, Cancer Immunol. Immunother, vol.56, pp.515-526, 2007.
URL : https://hal.archives-ouvertes.fr/inserm-02482050

M. E. Dudley, J. R. Wunderlich, P. F. Robbins, J. C. Yang, P. Hwu et al., Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytes, Science, vol.298, pp.850-854, 2002.

A. Mackensen, N. Meidenbauer, S. Vogl, M. Laumer, J. Berger et al., Phase I study of adoptive T-cell therapy using antigenspecific CD81T cells for the treatment of patients with metastatic melanoma, J. Clin. Oncol, vol.24, pp.5060-5069, 2006.

N. Meidenbauer, J. Marienhagen, M. Laumer, S. Vogl, J. Heymann et al., Survival and tumor localization of adoptively transferred Melan-A-specific T cells in melanoma patients

, J. Immunol, vol.170, pp.2161-2169, 2003.

V. Vignard, B. Lemercier, A. Lim, M. C. Pandolfino, Y. Guilloux et al., Adoptive transfer of tumor-reactive Melan-A-specific CTL clones in melanoma patients is followed by increased frequencies of additional Melan-A-specific T cells, J. Immunol, vol.175, pp.4797-4805, 2005.

C. Yee, J. A. Thompson, D. Byrd, S. R. Riddell, P. Roche et al., Adoptive T cell therapy using antigen-specific CD81T cell clones for the treatment of patients with metastatic melanoma: in vivo persistence, migration, and antitumor effect of transferred T cells, Proc. Natl. Acad. Sci, vol.99, pp.16168-16173, 2002.

, Clinical immunology, vol.40, pp.1786-1794, 2010.

Y. Godet, A. Moreau-aubry, Y. Guilloux, V. Vignard, A. Khammari et al., MELOE-1 is a new antigen overexpressed in melanomas and involved in adoptive T cell transfer efficiency, J. Exp. Med, vol.205, pp.2673-2682, 2008.

G. A. Rizzuto, T. Merghoub, D. Hirschhorn-cymerman, C. Liu, A. M. Lesokhin et al., Self-antigen-specific CD81T cell precursor frequency determines the quality of the antitumor immune response, J. Exp. Med, vol.206, pp.849-866, 2009.

P. R. Dunbar, C. L. Smith, D. Chao, M. Salio, D. Shepherd et al., A shift in the phenotype of melan-A-specific CTL identifies melanoma patients with an active tumor-specific immune response

, J. Immunol, vol.165, pp.6644-6652, 2000.

M. J. Pittet, A. Zippelius, D. Valmori, D. E. Speiser, J. C. Cerottini et al., Melan-A/MART-1-specific CD8 T cells: from thymus to tumor, Trends Immunol, vol.23, pp.325-328, 2002.

A. Zippelius, M. J. Pittet, P. Batard, N. Rufer, M. De-smedt et al., Thymic selection generates a large T cell pool recognizing a self-peptide in humans, J. Exp. Med, vol.195, pp.485-494, 2002.

P. Chaux, V. Vantomme, P. Coulie, T. Boon, and P. Van-der-bruggen, Estimation of the frequencies of anti-MAGE-3 cytolytic T-lymphocyte precursors in blood from individuals without cancer, Int. J. Cancer, vol.77, pp.538-542, 1998.

P. Y. Dietrich, F. A. Le-gal, V. Dutoit, M. J. Pittet, L. Trautman et al., Prevalent role of TCR alpha-chain in the selection of the preimmune repertoire specific for a human tumor-associated selfantigen, J. Immunol, vol.170, pp.5103-5109, 2003.

L. Trautmann, N. Labarriere, F. Jotereau, V. Karanikas, N. Gervois et al., Dominant TCR V alpha usage by virus and tumor-reactive T cells with wide affinity ranges for their specific antigens, Eur. J. Immunol, vol.32, pp.3181-3190, 2002.

Y. H. Ding, K. J. Smith, D. N. Garboczi, U. Utz, W. E. Biddison et al., Two human T cell receptors bind in a similar diagonal mode to the HLA-A2/Tax peptide complex using different TCR amino acids, Immunity, vol.8, pp.403-411, 1998.

K. C. Garcia, M. Degano, L. R. Pease, M. Huang, P. A. Peterson et al., Structural basis of plasticity in T cell receptor recognition of a self peptide-MHC antigen, Science, vol.279, pp.1166-1172, 1998.

J. J. Moon, H. H. Chu, M. Pepper, S. J. Mcsorley, S. C. Jameson et al., Naïve CD4(1)T cell frequency varies for different epitopes and predicts repertoire diversity and response magnitude, Immunity, vol.27, pp.203-213, 2007.

C. A. Klebanoff, L. Gattinoni, and N. P. Restifo, CD81T-cell memory in tumor immunology and immunotherapy, Immunol. Rev, vol.211, pp.214-224, 2006.

C. A. Klebanoff, L. Gattinoni, P. Torabi-parizi, K. Kerstann, A. R. Cardones et al., Central memory self/tumorreactive CD81T cells confer superior antitumor immunity compared with effector memory T cells, Proc. Natl. Acad. Sci, vol.102, pp.9571-9576, 2005.

L. Tussey, S. Speller, A. Gallimore, and R. Vessey, Functionally distinct CD8 1 memory T cell subsets in persistent EBV infection are differentiate d by migratory receptor expression, Eur. J. Immunol, vol.30, pp.1823-1829, 2000.

M. Bodinier, M. A. Peyrat, C. Tournay, F. Davodeau, F. Romagne et al., Efficient detection and immunomagnetic sorting of specific T cells using multimers of MHC class I and peptide with reduced CD8 binding, Nat. Med, vol.6, pp.707-710, 2000.

N. Labarriere, N. Gervois, A. Bonnin, R. Bouquie, F. Jotereau et al., PBMC are as good a source of tumor-reactive T lymphocytes as TIL after selection by Melan-A/A2 multimer immunomagnetic sorting, Cancer Immunol. Immunother, vol.57, pp.185-195, 2008.
URL : https://hal.archives-ouvertes.fr/inserm-00167752

M. J. Pittet, D. Valmori, P. R. Dunbar, D. E. Speiser, D. Lienard et al., High frequencies of naïve Melan-A/ MART-1-specific CD8(1) T cells in a large proportion of human histocompatibility leukocyte antigen (HLA)-A2 individuals, J. Exp. Med, vol.190, pp.705-715, 1999.

C. Lonchay, P. Van-der-bruggen, T. Connerotte, T. Hanagiri, P. Coulie et al., Correlation between tumor regression and T cell responses in melanoma patients vaccinated with a MAGE antigen, Proc

, Natl. Acad. Sci. USA, vol.101, pp.14631-14638, 2004.

D. Valmori, V. Dutoit, D. Lienard, D. Rimoldi, M. J. Pittet et al., Naturally occurring human lymphocyte antigen-A2 restricted CD81T-cell response to the cancer testis antigen NY-ESO-1 in melanoma patients, Cancer Res, vol.60, pp.4499-4506, 2000.

V. Voelter, N. Rufer, S. Reynard, G. Greub, R. Brookes et al., Characterization of Melan-A reactive memory CD81T cells in a healthy donor, Int. Immunol, vol.20, pp.1087-1096, 2008.

M. Correia-neves, C. Waltzinger, D. Mathis, and C. Benoist, The shaping of the T cell repertoire, Immunity, vol.14, pp.21-32, 2001.

D. B. Sant'angelo, P. G. Waterbury, B. E. Cohen, W. D. Martin, L. Van-kaer et al., The imprint of intrathymic self-peptides on the mature T cell receptor repertoire, Immunity, vol.7, pp.517-524, 1997.

N. Gervois, N. Labarriere, S. Le-guiner, M. C. Pandolfino, J. F. Fonteneau et al., High avidity melanoma-reactive cytotoxic T lymphocytes are efficiently induced from peripheral blood lymphocytes on stimulation by peptide-pulsed melanoma cells, Clin. Cancer Res, vol.6, pp.1459-1467, 2000.
URL : https://hal.archives-ouvertes.fr/inserm-02482162

F. Jotereau, M. C. Pandolfino, D. Boudart, E. Diez, B. Dreno et al., High-fold expansion of human cytotoxic T-lymphocytes specific for autologous melanoma cells for use in immunotherapy, J. Immunother, vol.10, pp.405-411, 1991.

F. Davodeau, M. Difilippantonio, E. Roldan, M. Malissen, J. L. Casanova et al., The tight interallelic positional coincidence that distinguishes T-cell receptor Jalpha usage does not result from homologous chromosomal pairing during ValphaJalpha rearrangement, EMBO J, vol.20, pp.4717-4729, 2001.

B. Arden, S. P. Clark, D. Kabelitz, and T. W. Mak, Human T-cell receptor variable gene segment families, Abbreviations: pMHC: peptide-MHC complexes Á TAA: Tumorassociated antigen Á TIL: tumor infiltrating lymphocytes Full correspondence: Dr. Nathalie Labarriere, CRCNA, Institut de Recherche Therapeutique, vol.42, p.44007, 1995.